Meparfynol

Meparfynol

SCHEMBL8033725

C#CC(C)(O)CC.NCC(=O)O

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADORA1ADORA2AADORA2BADORA3PDE3APDE3BPDE4APDE4BPDE4CPDE4D

The experimentally established mechanism targets of Meparfynol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
GLRA1 P23415 1/20 0.42
SLC6A9 P48067 1/20 0.42
OR51E2 Q9H255 1/20 0.42
HMGCR P04035 1/20 0.34
CHRM1 P11229 1/20 0.34
TBXA2R P21731 1/20 0.34
ADRA1A P35348 1/20 0.34
KDM4E B2RXH2 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.33
MEN1 O00255 1/20 0.31
ALDH1A1 P00352 1/20 0.31
CYP1A2 P05177 1/20 0.31
THRB P10828 1/20 0.31
KMT2A Q03164 1/20 0.31
FFAR3 O14843 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Meparfynol SCHEMBL1171790 0.87 L3MBTL1 (0.35) HMGCRCHRM1TBXA2RADRA1AL3MBTL1
Meparfynol SCHEMBL12864498 0.82
Meparfynol SCHEMBL547715 0.82
Meparfynol SCHEMBL78626 0.82
Meparfynol SCHEMBL28814077 0.79
Meparfynol SCHEMBL11215486 0.79
Glycine SCHEMBL28051006 0.77 GLRA1 (0.56) GLRA1SLC6A9OR51E2HMGCRCHRM1
Meparfynol SCHEMBL3459559 0.73 TSHR (0.33) MEN1ALDH1A1THRBKMT2A
SCHEMBL31605870 0.69
Tert-Butylamine SCHEMBL29128848 0.69 GLRA1 (0.67) GLRA1SLC6A9OR51E2HMGCRCHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6051222-A CANCER DIAGNOSIS; GENETIC ENGINEERING HUMAN GENOME SCIENCES, INC. (US) 2000-04-18 US disclosed
US-6033870-A Human transmembrane protein INCYTE PHARMACEUTICALS, INC. (US) 2000-03-07 US disclosed
US-6010852-A Human proton atpase subunit INCYTE PHARMACEUTICALS, INC. (US) 2000-01-04 US disclosed
US-5985287-A POLYPEPTIDES COMPRISING AN IMMUNOGENIC PORTION OF A M. VACCAE PROTEIN AND DNA MOLECULES ENCODING SUCH POLYPEPTIDES, ADMINISTERING DELIPIDATED AND DEGLYCOLIPIDATED M. VACCAE CELLS. GENESIS RESEARCH AND DEVELOPMENT CORPORATION LIMITED (NZ) 1999-11-16 US disclosed
US-5932470-A FOR DETECTION AND TREATMENT OF ALLERGIC DERMATITIS IN ANIMALS HESKA CORPORATION (US) 1999-08-03 US disclosed
US-5928941-A NUCLEOTIDE SEQUENCES THAT ENCODE A ZINC FINGER PROTEIN WITH CONSERVED DOMAINS; ANTITUMOR AGENTS AND SUPPRESSORS OF HYPERPLASIAS PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 1999-07-27 US disclosed
US-5928915-A NUCLEOTIDE SEQUENCES THAT CODES FOR A CYTOSOLIC ENZYME FROM CHINESE HAMSTER OVARIES; DIAGNOSIS, ANTIFLAMMATORY AGENTS; ANTIARTHRITIC AGENTS, ANTITUBERCULAR AGENTS, AND VIRICIDES GENENTECH, INC. (US) 1999-07-27 US disclosed
US-5922566-A POLYNUCLEOTIDE INCYTE PHARMACEUTICALS, INC. (US) 1999-07-13 US disclosed
US-5914393-A NUCLEIC ACIDS CODING FOR JANUS FAMILY NORECEPTOR PROTEINS TYROSINE KINASE; ANTISENSE/ANTICARCINOGENIC/ANTIARTHRITIC ANTIDIABETIC AGENTS INCYTE PHARMACEUTICALS, INC. (US) 1999-06-22 US disclosed
US-5910442-A NUCLEIC ACID CODING FOR SUBSTRATE OF PROTEIN KINASE C INSERTING IT INTO A EXPRESSION VECTOR; TRANSFORMING A HOST; ANTICARCINOGENIC AGENTS MOUNT SINAI SCHOOL OF MEDICINE (US) 1999-06-08 US disclosed